Business Description
Qyuns Therapeutics Co Ltd
ISIN : CNE1000069W9
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.3 | |||||
Equity-to-Asset | 0.34 | |||||
Debt-to-Equity | 1.36 | |||||
Debt-to-EBITDA | -2.09 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 10.66 | |||||
9-Day RSI | 17.03 | |||||
14-Day RSI | 23.73 | |||||
6-1 Month Momentum % | 29.5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.86 | |||||
Quick Ratio | 1.83 | |||||
Cash Ratio | 1.7 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -2.54 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -70.99 | |||||
ROA % | -27.72 | |||||
ROIC % | -46.59 | |||||
ROC (Joel Greenblatt) % | -71.49 | |||||
ROCE % | -39.13 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 7.63 | |||||
Price-to-Tangible-Book | 7.72 | |||||
EV-to-EBIT | -10.53 | |||||
EV-to-EBITDA | -10.9 | |||||
EV-to-FCF | -23.55 | |||||
Price-to-Net-Current-Asset-Value | 452.67 | |||||
Earnings Yield (Greenblatt) % | -9.5 | |||||
FCF Yield % | -4.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Qyuns Therapeutics Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | |||
EPS (TTM) (HK$) | -1.219 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 23.73 | ||
14-Day ATR (HK$) | 1.862917 | ||
20-Day SMA (HK$) | 20.913 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (HK$) | 13.42 - 30.95 | ||
Shares Outstanding (Mil) | 222.07 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Qyuns Therapeutics Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Qyuns Therapeutics Co Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Qyuns Therapeutics Co Ltd Frequently Asked Questions
What is Qyuns Therapeutics Co Ltd(HKSE:02509)'s stock price today?
When is next earnings date of Qyuns Therapeutics Co Ltd(HKSE:02509)?
Does Qyuns Therapeutics Co Ltd(HKSE:02509) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |